DULERA (formoterol fumarate; mometasone furoate) Merck sharp dohme Patent: 7,566,705 Expiration: Nov 21, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent Expiratio…
Drug Patent Expirations for the Week of November 15, 2020 Read Post »
Annual Drug Patent Expirations for WAKIX Wakix is a drug marketed by Harmony and is included in one NDA. There are five patents protecting this drug. This drug has seventy-two…
The post New patent for Harmony drug WAKIX appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent for Sunovion Pharms drug KYNMOBI appeared first on DrugP…
This chart shows the pharmaceutical companies with the most patents in Japan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug patent…
Which pharmaceutical companies have the most drug patents in Japan? Read Post »
Annual Drug Patent Expirations for BAQSIMI Baqsimi is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent for Eli Lilly drug BAQSIMI appeared first on DrugPatentWatch – Make …
Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are three patents protecting…
The post New patent for Chiesi drug FERRIPROX appeared first on D…
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…
New patent for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE appear…
New patent for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on DrugP…
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fi…
Get new actionable insights and updates from BiotechBlog
